Guidant Corporation (Indianapolis, Ind.) received FDA approval for its Vitality 2 implantable defibrillator, which is indicated for patients at risk for sudden cardiac death due to arrhythmia.
The Vitality 2 is the smallest, thinnest implantable defibrillator on the market. At 30 cc and 11 mm, it is designed to make insertion easier and contribute to patient comfort.
The Vitality 2 also uses the company's RHYTHM ID feature, which uses rhythm discrimination technology to help manage complex arrhythmias and distinguish between lethal and nonlethal arrhythmia.
For more information, visit http://www.guidant.com.